Long-term research presented at #ISTH25 affirmed that CHIP has an independent negative effect on overall survival, but treatments for #CoronaryArteryDisease in patients who were CHIP-positive did not help overcome this effect: ow.ly/kH1m50WARhs
#HemeSky #MedSky

The August issue is out now! Highlights include a feature on the current state of #GeneTherapy in #hematology, meeting coverage of #ISTH25, a debate on combination therapy for #myelofibrosis, and more. Check out the full lineup here: ow.ly/aoFJ50WzHvK 🩸
#HemeSky #MedSky

#ISTH25 Use of the EULAR 2023 criteria — developed to refine the classification of #AntiphospholipidSyndrome — was found to improve specificity compared with the 2006 Sydney criteria but resulted in decreased sensitivity, leaving many patients excluded: ow.ly/s3Ta50WzHlU
#HemeSky #thrombosis

Are you attending #ISTH25? Keep an eye out for upcoming highlights from this year’s event, on demand with Medthority. In the meantime, catch up with key discussions from last year’s event, including real-world evidence and stroke prevention in AF #MedSky #MedEd

ow.ly/SBiG50WeOeq

I can’t wait to see all of my Thrombosis friends at #ISTH25 in Washington, DC next summer!

Calling #medsky #surgsky #pharmsky #GIsky #hemesky and anyone else who manages anticoagulation, thrombosis and bleeding: join us at #ISTH25 in DC!
podcasts.apple.com/ie/podcast/i...